David Weill, Director at TransMedics Group, Inc. (TMDX), sold 21,645 shares at $56.00 ($1.2M) on 2022-11-10, disclosed to the SEC on 2022-11-14.
Open-market sale of $1.2M TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMDX | SELL | 2025-12-05 | $1.4M | — | Filing → |
| TMDX | SELL | 2025-05-23 | $181K | — | Filing → |
| TMDX | SELL | 2024-05-31 | $338K | — | Filing → |